RCT Implant Based Breast Reconstruction

University of Colorado Denver (CU Denver) logo

University of Colorado Denver (CU Denver)






Other: Discharge timing

Study type


Funder types



P30CA046934 (U.S. NIH Grant/Contract)

Details and patient eligibility


The main objective of this study is to evaluate patients undergoing mastectomy with immediate implant-based breast reconstruction and compare the outcomes of patients who are discharged the day of surgery versus patients who are discharged on post-operative day one. The primary aim of the study will be to compare the postoperative outcomes and complications between the two study groups within 30 days of discharge. The secondary aims of the study will be to compare patient satisfaction, quality of life and discharge perceptions.

Full description

Traditionally patients undergoing mastectomy with immediate implant-based breast reconstruction were admitted to the hospital overnight. However, recent retrospective studies utilizing ERAS protocols have reported same day discharge as a possibility for this patient population. ERAS protocols for breast cancer surgery and reconstruction are becoming more popular. This along with the increasing utilization of prepectoral breast reconstruction that is associated with less postoperative pain and opioid use, are promising avenues to decrease the need for overnight hospital stay. If it can be shown that discharge on the same day of surgery does not pose any major risks compared to discharge on post-operative day one, there is the potential to decrease length of hospital stay, improve hospital capacity and dramatically decrease costs.


100 estimated patients




19 to 80 years old


No Healthy Volunteers

Inclusion criteria

  • Patients who will undergo immediate, (unilateral or bilateral)implant-based breast reconstruction following mastectomy for breast cancer or prophylaxis at the University of Colorado Anschutz Medical Campus and Highlands Ranch Campus.
  • Patients undergoing sub-pectoral and pre-pectoral breast implant reconstructive techniques will be both included.
  • All adult (>18 years old), female patients who will undergo mastectomy for breast cancer or prophylaxis and immediate implant-based reconstruction who are able to complete surveys independently will be eligible for the study.
  • English and Spanish speaking
  • Patients will be included regardless of their current chemoradiation plan

Exclusion criteria

  • Age > 80 years
  • ASA 4
  • suboxone use
  • documented substance use disorder as defined by the DSM-5 (I.e. alcohol use disorder, opioid use disodrer, cocaine use disorder, etc). Marijuana use will not be considered a substance use disorder
  • OSA requiring CPAP
  • recent pneumonia (within 6 weeks)
  • BMI > 45 kg/m2 with any co-morbid condition that is not well controlled
  • poorly controlled diabetes (HgbA1c > 9)
  • Not English or Spanish speaking

Trial design

100 participants in 2 patient groups

Discharge day of surgery
Experimental group
Patient discharges day of surgery and given surveys to complete at home on post operative day (POD) #1 and #7.
Other: Discharge timing
Discharge post operative day 1
No Intervention group
Patient Discharges POD #1 and completes survey prior to discharge. Patient given surveys to complete POD #7 at home.

Trial contacts and locations



Central trial contact

Christodoulos Kaoutzanis

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems